Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron PharmafiledCriticalRegeneron Pharma
Priority claimed from PCT/US2016/024343external-prioritypatent/WO2016160615A1/en
Publication of MA41065A1publicationCriticalpatent/MA41065A1/en
Publication of MA41065B1publicationCriticalpatent/MA41065B1/en
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La présente invention concerne des dérivés de maytansinoïde, des conjugués de ceux-ci, et des procédés de traitement ou de prévention de maladies prolifératives à l'aide de ceux-ci.The present invention relates to maytansinoid derivatives, conjugates thereof, and methods of treating or preventing proliferative diseases using them.
MA41065A2015-03-272016-03-25
Maytansinoid derivatives, conjugates thereof, and methods of use
MA41065B1
(en)